Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rui-Fei Xie"'
Publikováno v:
Medicine. 101(52)
Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related burden and deaths, thus effective treatment strategies with lower side effects for NSCLC are urgently needed. To systematically analyze the mechanism of Bai He Gu Jin Tang (BHGJT
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Systemic lupus erythematosus (SLE) is a refractory autoimmune disease. Zhibai Dihuang Wan (ZDW) has frequently been used for treating SLE in China and been proved to have a prominent role in decreasing SLE patients’ morality rate. However, the acti
Autor:
Hong Fang Zhang, Rui Fei Xie, Shi Xiu Wu, Ling Yang, Qiang Hou, Xiao Yan Zhang, Jing Yue, Ming Huang, Zhenzhen Jiang, Rongjing Zhou, Ying Li
Publikováno v:
Journal of Clinical Oncology. 36:e15699-e15699
e15699Background: Tumor heterogeneity and internal clonal evolution of human colorectal cancer stem cells (CRCSCs) within cancerous tissues often represents an aggressive feature of cancer progress...
Publikováno v:
International journal of clinical and experimental medicine. 8(4)
IMRT has achieved an excellent survival and less radiation-induced sequelae with improvement of QoL within 2 years compared to conventional radiotherapy for NPC. Whether IMRT could sustained decrease incidence of late sequelae and improve QoL further
Autor:
Hong Fang Zhang, Wen Xin Li, Yu Hui Hua, Hong Lei Luo, Hong Jin Wu, Shi Xiu Wu, Xiao Yan Zhang, Zhao Jing, Rui Fei Xie
Publikováno v:
Journal of Clinical Oncology. 35:e15523-e15523
e15523 Background: The outcomes of inoperable esophageal squamous carcinoma (ESCC) patients treated with concurrent chemoradiotherapy remain poor. The discovery of novel biomarkers for predicting prognosis could allow for more accurate risk stratific